Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 22-001884
Sponsor Protocol Number: 22-001884
About this study
The objective of this study is to explore the perceptions of under- and uninsured, Hispanic women living in Maricopa County around mammography screening to understand if deploying a BRCA model in community settings is a culturally acceptable strategy for reducing disparities in mammography access and use.
In 2019, breast cancer (BC) was the leading cause of death among Hispanic women in Maricopa County, Arizona (AZ) – Mayo Clinic Arizona’s (MCA) primary catchment area where Hispanics comprise 30% of the population. Mammography screening has been associated with a nearly 25% reduction in mortality, but Hispanic women have a lower incidence of mammography screening and are twice as likely to report barriers to accessing care compared to non-Hispanic White women. Federally Qualified Health Centers (FQHCs) are safety net providers that can help reduce disparities in mammography screening by providing screening services on site or referring patients to other clinics. Unfortunately, there is the only one FQHC in the County that provides screening on site. Preliminary data and feedback from community stakeholders suggest that the limited presence of mammography facilities, challenges accessing and affording health care, as well as other contextual factors (cultural beliefs, transportation, age, literacy) may explain disparities in BC screening and mortality.
Risk-based screening may bring considerable benefits by directing the limited screening and preventive resources available in Maricopa County to women most in need. Guideline recommendations call for the implementation of individualized breast cancer risk assessment (BRCA) in primary care settings, but implementation may prove challenging for FQHCs in Maricopa County that are chronically overburden and underresourced. This proposed research is significant for its potential to reduce disparities in BC screening and mortality by exploring the use of BRCA models in community settings as a strategy to identify Hispanic women at increased BC risk for targeted interventions.
Before this innovative strategy is introduced, we must understand women’s perceptions around risk, barriers to accessing mammography screening, and acceptability (i.e., attitudes, beliefs, barriers, and facilitators) of BRCA. The objective of this pilot study is to explore the cultural acceptability of performing BCRA in community settings as a strategy to promote access and use of mammography screening among under and uninsured, Hispanic women in Maricopa County.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
HISPANIC WOMEN ENROLLED IN THE LLEAD STUDY
Inclusion Criteria:
- Completed a baseline survey for the LLEAD study.
- Self-identify as Hispanic.
- Between 40-65 years of age.
Exclusion Criteria:
WOMEN WITH A HISTORY OF BREAST CANCER
Inclusion Criteria:
- Between the ages of 45 and 65.
- Self-identify as Hispanic.
- Current residence in Maricopa County.
- Be under- (e.g., Arizona Health Care Cost Containment System) or uninsured at the time of enrollment.
- Can read and speak English or Spanish well enough to understand and complete the informed consent process and take part in either a focus group or individual interview.
Exclusion Criteria:
- Women with a history of breast cancer.
Eligibility last updated 3/7/22. Questions regarding updates should be directed to the study team contact.